Laboratory Products

  • GM Chickens Lay Eggs Containing Drugs

GM Chickens Lay Eggs Containing Drugs

Feb 19 2019 Read 1169 Times

The words ‘genetically modified’ have negative connotations for a lot of people. However, the results can also be highly beneficial in a number of ways. One example of this is came recently when scientists genetically modified chickens to create drugs when they lay eggs. The modification didn’t affect the chickens’ health and could massively help sufferers of conditions like arthritis and some cancers. Read on as we look at the ground-breaking research.

Cost-effective medicines

A huge number of human diseases occur because the body simply does not produce enough of a certain chemical or protein naturally. These disorders or illnesses can be maintained and even treated using drugs that contain the protein the body is deficient in. To find out more about the identification of specific chemicals, check out the article ‘Characterising Unknowns: Behind the Scenes of Chemical Investigation’.

But what if those chemicals or proteins could still be made naturally? Dr Herron and her team of researchers inserted a human gene, which typically produces the necessary protein in humans, into part of the chicken’s DNA that produces the white part of eggs.

The chicken is not harmed during the modification and continues to lay eggs as normal, with no impact on their health. Once the eggs had been laid and cracked open, Dr Herron and her team discovered that the egg whites contained relatively large quantities of the required protein.

The drugs produced using genetically modified chickens are around 100 times cheaper to produce than when manufactured in laboratories or factories. Chicken sheds are much cheaper to build and maintain than a factory, especially with reduced need for highly sterile environments.

Medical progression

Dr Herron and her team focused on two main proteins that are vital for the human immune system: IFNalpha2a, which has powerful antiviral and anti-cancer effects, and macrophage-CSF, which is currently being developed to stimulate damaged tissue to repair itself.

To produce one dose of the drug, scientists will need three eggs, and the chickens can lay up to 300 eggs per year. With enough chickens, Dr Herron and her team believe that they will be able to produce drugs in commercial quantities. They are hopeful that the development of the drugs for human consumption will take around 10-20 years.

In the meantime, they believe the eggs will be able to be used to develop drugs for animal health. “For example, we could use (the drugs) in regenerating the liver or the kidneys or a pet that has suffered damage to these organs”, explained Dr Herron. By offering a cheaper, readily-available medicine alternative, there is hope to treat and cure more pets of potentially fatal illnesses.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

Lab Asia April 2019

April 2019

In This Edition Articles - Mobile Affinity Sorbent Chromatography Of Proteins - Integration of MS and UV Data for Peak Tracking in HPLC Method Development - VMXm takes its First Users 'wher...

View all digital editions


ASMS Conference

Jun 02 2019 Atlanta, GA, USA

Drug Discovery Summit

Jun 10 2019 Berlin, Germany

HPLC 2019

Jun 16 2019 Milan, Italy

Chemspec Europe

Jun 26 2019 Basel, Switzerland

View all events